Comprehensive 2025 Drug Infusion Systems Market Overview: Trends, Forecasts, and Growth Drivers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Is the Expected CAGR for the Drug Infusion Systems Market Through 2025?_x000D_
The market for drug infusion systems has significantly expanded in the past few years. The market, currently valued at $13.42 billion in 2024, is projected to climb to $14.34 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.9%. The historic expansion can be credited to several factors such as the transition to electronic infusion instruments, the rising incidence of chronic conditions, improvements in patient care, the emergence of home-based infusion therapy, and the development of ambulatory care environments._x000D_
_x000D_
What's the Projected Size of the Global Drug Infusion Systems Market by 2029?_x000D_
In the upcoming years, the market for drug infusion systems is predicted to experience robust growth. It is anticipated to reach "$20.46 billion in 2029, growing at a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the growth during this projected period include the shift towards disposable systems, the increasing occurrence of chronic diseases, the growth of ambulatory care facilities, personalised medicine and adaptive dosing, as well as the rising demand for at-home care. Key trends anticipated for this forecast period encompass wireless connectivity and remote monitoring, combination with electronic health record (ehr), smart pump technology, personalised and adaptive dosing, and minimally invasive infusion methods._x000D_
_x000D_
View the full report here:_x000D_
https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report_x000D_
_x000D_
Top Growth Drivers in the Drug Infusion Systems Industry: What's Accelerating the Market?_x000D_
The surge in chronic diseases is anticipated to drive the expansion of the drug infusion system market. These chronic illnesses, including cancer, diabetes, cardiovascular disease, and autoimmune disorders, often necessitate long-term or ongoing infusion therapy. Drug infusion systems provide a secure, efficient, and effective method of dispensing drugs to these patients. The incidence of these diseases has been rising more rapidly in low-and middle-income countries than in their wealthier counterparts. Diabetes, a major contributor to kidney failure, heart attacks, strokes, blindness, and amputations of the lower limb. For example, data published by the Centers for Disease Control and Prevention (CDC), a US-based entity, in February 2024, indicate that an increasing percentage of Americans struggle with multiple chronic conditions, with 42% having at least two and 12% having five or more. Hence, the rising demand due to increasing prevalence of chronic diseases fuels the expansion of the drug infusion system market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp_x000D_
_x000D_
What Trends Will Shape the Drug Infusion Systems Market Through 2029 and Beyond?_x000D_
Key players in the drug infusion systems market, such as Eitan Medical, have been at the forefront of adopting innovative tech solutions like cloud-aided infusion management systems. This technology is designed to heighten patient care, increase accuracy, and make the overseeing of infusion therapies more efficient. These systems are digital platforms, hosted on the cloud, which aid in observing, administering, and keeping track of medication infusions. In June 2023, Eitan Medical, recognized worldwide for drug delivery solutions and advanced infusion therapies, unveiled their product Eitan Insights. This new system is tailored specifically for home and specialized infusions, with a focus on real-time data and analytics that allows medical personnel to remotely monitor patients and adjust treatment plans as required. Eitan Insights aims to amplify medication safety by minimizing errors and ensuring adherence to prescribed treatment plans._x000D_
_x000D_
What Are the Main Segments in the Drug Infusion Systems Market?_x000D_
The drug infusion systems market covered in this report is segmented -_x000D_
_x000D_
1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System_x000D_
2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration_x000D_
3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications_x000D_
4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps_x000D_
2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components_x000D_
3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps_x000D_
4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps_x000D_
5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies_x000D_
6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps_x000D_
7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps_x000D_
8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp_x000D_
_x000D_
Which Top Companies are Driving Growth in the Drug Infusion Systems Market?_x000D_
Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton inson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc._x000D_
_x000D_
Which Regions Will Dominate the Drug Infusion Systems Market Through 2029?_x000D_
North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703_x000D_
_x000D_
This Report Supports:_x000D_
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_
Learn More About The Business Research Company_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead._x000D_
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making._x000D_
_x000D_
Reach out to us:_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Europe: +44 207 1930 708_x000D_
Asia: +91 88972 63534_x000D_
Americas: +1 315 623 0293_x000D_
Email: info@tbrc.info_x000D_
_x000D_
Follow Us On:_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
Twitter: https://twitter.com/tbrc_info_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.